|
Market Closed -
Bombay S.E.
14:02:28 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 125.30 INR | +1.21% |
|
-1.38% | -3.62% |
| Market Cap | 1.44B 15M 13.08M 12.35M 11.21M 21.01M 21.1M 148M 57.08M 732M 56.34M 55.09M 2.35B | P/E 2025 |
10.7x | P/E 2026 | 12.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2.24B 23.39M 20.4M 19.26M 17.49M 32.77M 32.9M 231M 89.02M 1.14B 87.86M 85.91M 3.67B | EV / Sales 2025 |
1.02x | EV / Sales 2026 | 0.92x |
| Free-Float |
14.66% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| PARNAXLAB | Delayed | |
NSE India S.E.
| PARNAXLAB | Delayed |
| 1 day | +1.21% | ||
| 1 week | -1.38% | ||
| Current month | -3.76% | ||
| 1 month | +6.19% | ||
| 3 months | -6.53% | ||
| 6 months | +4.42% | ||
| Current year | -3.62% |
| 1 week | 118.5 | 129.15 | |
| 1 month | 116 | 151.9 | |
| Current year | 99.2 | 182 | |
| 1 year | 99.2 | 182 | |
| 3 years | 75.6 | 193.5 | |
| 5 years | 22 | 193.5 | |
| 10 years | 11.65 | 193.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 05/07/2024 | |
Binoy Baiju Shah
DFI | Director of Finance/CFO | 42 | 05/07/2024 |
| Compliance Officer | - | 21/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Ami Mihir Shah
BRD | Director/Board Member | 50 | 31/03/2015 |
| Director/Board Member | 72 | 28/05/2021 | |
| Director/Board Member | 66 | 11/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.21% | -1.38% | -8.10% | +35.90% | 15M | ||
| -0.58% | +0.43% | +31.09% | -4.81% | 78.35B | ||
| -2.55% | +6.99% | +505.27% | +47.92% | 61.52B | ||
| -1.11% | +5.08% | -11.47% | -33.91% | 59.78B | ||
| +0.14% | -1.20% | -11.64% | +24.21% | 46.53B | ||
| -0.24% | +1.22% | +2.26% | +151.03% | 45.5B | ||
| -1.62% | -0.76% | +49.85% | -14.92% | 31.84B | ||
| -1.81% | +3.16% | +45.71% | +110.57% | 25.4B | ||
| +0.47% | +3.26% | -0.77% | +142.41% | 21.43B | ||
| +0.27% | +1.96% | +62.19% | +102.81% | 15.77B | ||
| Average | -0.58% | +1.84% | +66.44% | +56.12% | 38.62B | |
| Weighted average by Cap. | -0.92% | +2.35% | +93.51% | +40.27% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.88B 19.57M 17.06M 16.11M 14.63M 27.41M 27.53M 193M 74.48M 955M 73.51M 71.88M 3.07B | 2.49B 25.91M 22.59M 21.33M 19.37M 36.29M 36.44M 256M 98.6M 1.26B 97.32M 95.16M 4.07B |
| Net income | 115M 1.2M 1.05M 988K 898K 1.68M 1.69M 11.84M 4.57M 58.56M 4.51M 4.41M 188M | 118M 1.23M 1.07M 1.01M 918K 1.72M 1.73M 12.1M 4.67M 59.87M 4.61M 4.51M 193M |
| Net Debt | 690M 7.19M 6.27M 5.92M 5.37M 10.07M 10.11M 70.9M 27.36M 351M 27M 26.4M 1.13B | 805M 8.39M 7.32M 6.91M 6.27M 11.76M 11.8M 82.76M 31.94M 409M 31.52M 30.82M 1.32B |
Employees
12
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | ₹125.30 | +1.21% | 673 |
| 17/09/26 | ₹123.80 | +1.68% | 93 |
| 16/09/26 | ₹121.75 | -1.81% | 1,891 |
| 15/09/26 | ₹124.00 | -2.40% | 1,486 |
| 11/09/26 | ₹127.05 | -3.49% | 256 |
- Stock Market
- Stocks
- PARNAXLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















